SUPPLEMENTAL STENT CONTINGENT STOCK RIGHTS AGREEMENTSupplemental Stent Contingent Stock Rights Agreement • March 23rd, 2009 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 23rd, 2009 Company Industry JurisdictionTHIS SUPPLEMENTAL STENT CONTINGENT STOCK RIGHTS AGREEMENT (this “Supplemental Agreement”), dated as of March 23, 2009, is entered into by and among Indevus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Endo Pharmaceuticals Holdings Inc., a Delaware corporation (“Endo”) and American Stock Transfer & Trust Company, as rights agent (the “Rights Agent”).